Dihydroergotamine nasal and OnabotulinumtoxinA Injection
Determining the interaction of Dihydroergotamine nasal and OnabotulinumtoxinA Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dihydroergotamine
Brand name: DHE. 45, Migranal
Synonyms: Dihydroergotamine (injection), Dihydroergotamine
Generic Name: onabotulinumtoxinA
Brand name: Botox, Botox Cosmetic
Synonyms: OnabotulinumtoxinA
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydroergotamine nasal-Onabotulinumtoxina Intramuscular
- Dihydroergotamine nasal-Onasemnogene Abeparvovcec Infusion
- Dihydroergotamine nasal-Onasemnogene Abeparvovec
- Dihydroergotamine nasal-Onasemnogene abeparvovec Zolgensma
- Dihydroergotamine nasal-Oncaspar
- Dihydroergotamine nasal-Oncovin
- OnabotulinumtoxinA Injection-Dihydroergotamine Nasal Spray
- OnabotulinumtoxinA Injection-Dilacor XR
- OnabotulinumtoxinA Injection-Dilantin
- OnabotulinumtoxinA Injection-Dilantin Infatabs
- OnabotulinumtoxinA Injection-Dilantin injection
- OnabotulinumtoxinA Injection-Dilantin Kapseals